Zimbabwe has rejected a major US healthcare agreement valued at $367m (£272m) over five years over Washington's request for sensitive biological samples.
This rejection came to light following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesman has since stated that the US was seeking health data for scientific study and profit while was unwilling to guarantee the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued talks to secure a deal acceptable to all parties so the country's critical HIV treatment initiative can proceed.
Broader Implications
Zimbabwe's decision follows a comparable case in Kenya, where a high court halted a similar deal with the US following concerns were raised about the safety of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and accountability.
According to reports, 16 African countries have so far agreed to these new agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no corresponding assurance of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," he stated.
"Effectively, our nation would provide the raw materials for medical research without any assurance that the end products would be available to our people should a new health crisis emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining frameworks already established via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.
"This system is intended to ensure that when a nation contributes its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how future collaboration might be designed in a manner that honours the independence and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that negotiations should continue considering a large portion of the country's Aids initiatives were funded by international support.
"Where specific concerns exist, such as those involving information security or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," the group commented.
The halted deal emphasises the ongoing challenges between accepting much-needed international aid and safeguarding national sovereignty in an ever more data-driven world.